Guidant News

Deborah was formerly at Guidant Corporation as a Director of R&D and New Ventures, and she currently has various advisory roles for the Georgia Institute of Technology, the Dystonia Medical Research Foundation, and the Association of Women in Science.

Boston Scientific Corporation is exploring the sale of its cardiac surgery and vascular surgery businesses in line with its proposed shedding of non-strategic assets, and to strengthen its operating and financial performance, by reducing debt incurred by the $27-billion acquisition of Guidant Corporation.

U.S. tax authorities have hit Boston Scientific Corp with a bill for $581 million in back taxes plus interest and penalties based on an audit of Guidant Corp from 2004 through 2006, the medical device maker said in a regulatory filing.

Hansen Medical named Peter J. Mariani as its chief financial officer. Hansen Medical Inc.

Shares of Boston Scientific Corp. plunged as much as 9% Tuesday after the medical device maker said that Chief Executive Ray Elliott would retire at the end of the year.